Arrowhead Pharmaceuticals Inc. (ARWR) Posts FY21 Loss of $1.36/Share
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $89.41 +1.72%
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
OPERATING LOSS: -19.34M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported FY 2021 EPS of ($1.36), versus ($0.84) last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
